In addition, the expression of E2F3, E2F4, E2F7 and E2F8 were significantly associated with tumor stages and overall survival of the patients with colon cancer, suggesting that they may serve as potential therapeutic targets for colon cancer. Here, E2F3 is linked to neoplasm.